Akebia Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AKBA and other ETFs, options, and stocks.About AKBA
Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the development and commercialization of drugs for the treatment of renal and metabolic disorders.
AKBA Key Statistics
Stock Snapshot
With a market cap of 468.37M, Akebia Therapeutics(AKBA) trades at $1.73. The stock has a price-to-earnings ratio of -23.13.
On 2025-11-18, Akebia Therapeutics(AKBA) stock moved within a range of $1.66 to $1.84. With shares now at $1.73, the stock is trading +4.2% above its intraday low and -5.7% below the session's peak.
Trading volume for Akebia Therapeutics(AKBA) stock has reached 6.18M, versus its average volume of 6.52M.
Over the past 52 weeks, Akebia Therapeutics(AKBA) stock has traded between a high of $4.08 and a low of $1.52.
Over the past 52 weeks, Akebia Therapeutics(AKBA) stock has traded between a high of $4.08 and a low of $1.52.
AKBA News
Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions AI Analyst can help you make smarter investment...
Akebia Therapeutics ((AKBA)) has held its Q3 earnings call. Read on for the main highlights of the call. Meet Your ETF AI Analyst Discover how TipRanks' ETF AI...